A PYMNTS Company

Germany/Japan: Panasonic Healthcare buys Bayer unit for €1 billion

By  |  June 10, 2015

Panasonic Healthcare Holdings agreed Wednesday to acquire the diabetes devices business of German conglomerate Bayer for 1.02 billion euros.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Bayer Diabetes Care or BDC, is one of the leading providers of blood glucose monitoring systems to people with diabetes and healthcare professionals around the world.

    The company expects to close the deal in the first quarter of 2016, subject to customary closing conditions, including relevant antitrust clearance.

    “We are confident that the sale of our Diabetes Care business to our long-standing partner Panasonic Healthcare, with the strong backing of KKR, will support the long-term sustainability of this portfolio,” said Werner Baumann, member of the Board of Management of Bayer AG and CEO of Bayer HealthCare.

    Full content: Blouin News

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.